vimarsana.com
Home
Live Updates
Orthox Announces MHRA Authorisation for Clinical Trial of Knee Cartilage Repair FibroFix Product Platform : vimarsana.com
Orthox Announces MHRA Authorisation for Clinical Trial of Knee Cartilage Repair FibroFix Product Platform
Key patent on implantable tissue repair devices granted in major economies OXFORD, England, July 13, 2022 /PRNewswire/ -- Orthox Limited, a clinical stage company developing medical implants
Related Keywords
Germany ,
Australia ,
Bristol ,
City Of ,
United Kingdom ,
Budapest ,
Hungary ,
China ,
Oxfordshire ,
France ,
Australian ,
Hungarian ,
Nick Skaer ,
Orthox Fibrofix ,
Michael Whitehouse ,
International Orthopaedics ,
Biomedical Catalyst Fund Award ,
Scius Communications ,
Bristol Biomedical Research Centre ,
Department Of Health ,
Wellcome ,
Stage Product Development ,
Prnewswire Orthox ,
University Of Bristol ,
Oxford University ,
European Innovation Council ,
United Kingdom Innovation Agency ,
Orthox Ltd ,
National Institute For Health ,
Care Research ,
Agency For Healthcare Research ,
National Institute ,
Wellcome Trust ,
Southmead Hospital ,
North Bristol ,
Fibrofix Cartilage ,
Study Chief Investigator ,
Biomedical Research Centre ,
Healthcare Research ,
Translation Awards ,
Late Stage Product Development Awards ,
Innovation Agency ,
United Kingdom Aid ,
Biomedical Research ,
Orthox ,
Nnounces ,
Phra ,
Authorisation ,
Linical ,
Trial ,
Knee ,
Cartilage ,
Repair ,
Ibrofix ,
Product ,
Platform ,
vimarsana.com © 2020. All Rights Reserved.